FoldRx Pharmaceuticals, Inc. to Raise Awareness of TTR Amyloidosis in Conjunction with NORD’s Rare Diseases Day

CAMBRIDGE, Mass.--(BUSINESS WIRE)--FoldRx announced today that it will host a program at its company headquarters on Friday, February 27 to raise awareness of rare diseases, including Transthyretin Amyloidosis (ATTR), a rare and fatal condition for which FoldRx is working to develop a treatment. The event is being held in conjunction with the National Organization for Rare Disorders (NORD) Rare Disease Day 2009 (www.rarediseaseday.org), of which FoldRx is one of the sponsors.